Literature DB >> 35098486

Experiences of adolescent and young adult cancer survivors during the COVID-19 pandemic.

Adam Yan1,2,3, Kaitlyn Howden4, Alyson L Mahar5,6, Ian Scott7, Camille Glidden8, Julie Deleemans9, Karine Chalifour10, Geoff Eaton10, Abha Gupta1,11, James M Bolton5,12, Sheila N Garland13, Sapna Oberoi14,15,16.   

Abstract

PURPOSE: This study aimed to evaluate the impact of the COVID-19 pandemic on adolescent and young adult (AYA) cancer survivors.
METHODS: We conducted a cross-sectional survey of AYAs aged 18-49 with cancer in Canada between January and February 2021. Data from survivors, defined as AYAs more than one year off cancer treatment, were analysed. Multiple logistic regression was used to identify factors associated with psychological distress, loneliness and insomnia.
RESULTS: The analysis included 384 survivors. Moderate-to-severe psychological distress was reported by 257 (68.9%) survivors and was associated with an income ≥ $60,000 (adjusted odds ratio [AOR] 2.15, 95% CI 1.11-4.17) and the presence of a pre-existing chronic physical health condition (AOR 2.05, 95% CI 1.18-3.56). Loneliness was reported by 204 (54.0%) survivors and was associated with being unemployed (AOR 2.26 95%CI 1.18-4.31), pandemic causing finances to be worse (AOR 1.82, 95%CI 1.08-3.06) and the presence of a pre-pandemic mental health condition (AOR 1.88, 95% CI 1.03-3.42). Clinical insomnia was reported by 74 (19.5%) survivors and was associated with employment status as a student (AOR 3.00, 95% CI 1.08-8.29) or unemployed (AOR 3.97, 95% CI 1.46-10.83), earning $60,000 or more in the year 2020 (AOR 4.36, 95% CI 1.43-13.32), having haematologic cancer (AOR 2.21, 95% CI 1.05-4.70) and being single (AOR 2.52, 95% CI 1.08-5.91). Pandemic negatively affected employment, finances, physical activity, cancer care and substance use for 73.9%, 66.5%, 32.5%, 21.8% and 19.2% of survivors, respectively. Worries about finances, contracting COVID-19, cancer treatment increasing the risk of COVID-19 infection, and having poor health outcomes from contracting COVID-19 were reported by 46.0%, 45.6%, 55.0% and 47.3% of survivors, respectively.
CONCLUSIONS: The COVID-19 pandemic has had a significant impact on AYA cancer survivors, and these individuals report high levels of psychological distress, insomnia and loneliness. IMPLICATIONS FOR CANCER SURVIVORS: Cancer survivors are at risk for worsening mental and physical health outcomes during the COVID-19 pandemic. Targeted interventions and support programs are urgently needed to support the mental health of AYA cancer survivors and optimize their health outcomes.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Adolescents and young adults; COVID-19; Cancer; Oncology; Pandemic; Survivorship

Year:  2022        PMID: 35098486      PMCID: PMC8801282          DOI: 10.1007/s11764-021-01158-9

Source DB:  PubMed          Journal:  J Cancer Surviv        ISSN: 1932-2259            Impact factor:   4.062


Introduction

Changes to healthcare delivery and societal interactions as a result of public health policies implemented during the COVID-19 pandemic have put cancer survivors at increased risk for adverse health outcomes [1-3]. To prevent viral spread, many healthcare centres are limiting in-person appointments, favouring the increased use of telemedicine for the delivery of health care [4, 5]. As cancer survivors who have completed treatment require less frequent clinical assessment and investigations and may be the first to be switched to virtual follow-up appointments [6]. These changes may limit access to essential in-person physical and mental health resources for this population [1]. Social distancing may also prevent cancer survivors from accessing indispensable support systems crucial for coping with the many challenges experienced in the survivorship period [2]. Adolescents and young adults (AYAs) diagnosed with cancer between 15 to 39 years of age often have complex medical, developmental and psychosocial needs. AYAs are more likely to face additional challenges in the survivorship period than their older counterparts [7, 8]. AYA cancer survivors often deal with a myriad of issues ranging from impaired physical and mental health, difficulties in continuing education and finding employment, challenges in finding and maintaining intimate and peer relationships, concerns about body image and fertility and financial hardships [7-9]. The societal and healthcare system shifts caused by the COVID-19 pandemic may worsen the already sub-optimal health and well-being of this population [7, 8, 10–16]. During the early phase of the pandemic, a survey of 177 AYAs with cancer demonstrated that one-fifth of participants completing cancer treatment more than six months ago were experiencing high levels of psychological distress [17]. Another qualitative study of 13 AYAs (18–29 years) with cancer conducted during the pandemic in Denmark found themes related to needing more supportive services, loneliness, challenges in connecting to the community and disruption of development [18]. However, a focused study examining the effect of COVID-19 on various aspects of the lives of AYA cancer survivors is lacking. Recognizing the impact of the ongoing pandemic on this population could provide crucial information that will help bridge the health gaps experienced by AYAs during this pandemic. Therefore, among AYAs who have survived cancer in Canada, we sought to determine the impact of the COVID-19 pandemic on their psychological distress, loneliness, insomnia, physical activity and finances, and to identify sociodemographic-, cancer- and health-related factors associated with psychological distress, loneliness and insomnia.

Methods

The data for this study were obtained from the impact of the COVID-19 pandemic on AYAs with cancer (ICOVIDAYA) study, a cross-sectional survey of AYAs living in Canada who were either undergoing active cancer therapy or had completed their treatment [19]. Participants were recruited via the social media platforms of the various national AYA cancer support groups across Canada, such as the Young Adult Cancer Canada (YACC) [20] and cancer clinics in Manitoba, to complete a 49-item self-administered anonymous online questionnaire between January and February 2021. The participants provided online informed consent prior to the completion of the survey. The questions relevant to this analysis are listed in Supplemental Methods Sect 1. Content experts developed the questionnaire using an established survey development methodology [21]. Patients were eligible for the study if they were diagnosed with cancer between 15 to 39 years of age and were currently 18 years of age or older. This paper represents the subset analysis of the ICOVIDAYA survey focusing solely on AYA cancer survivors, aged 18–49, who were at least one or more years post-treatment. The Research Ethics Board approved the study at the University of Manitoba (HS: 24501).

Survey measures

We collected sociodemographic information including age (18–25 vs. 26–39. vs. 40–50), gender (man vs. woman), ethnicity (white vs. non-white), Canadian province or territory of residence (British Columbia vs. Prairies vs. Central Canada vs. Atlantic Canada vs. Territories), living environment (urban vs. rural/remote), relationship status (single vs. in a relationship), employment status (employed vs. student vs. unemployed vs. caregiver/homemaker, disability/unemployment benefits vs. other), personal income in the year 2020 in CAD (< $40,000 vs. $40–60,000 vs. ≥ $60,000), and the number of days of physical activity and exercise per week (0 vs. 1–2 vs. 2–4 vs. 5–7 days per week). In addition, we collected information on self-reported pre-pandemic mental health conditions (yes vs. no), and chronic health conditions (yes vs. no) and cancer therapy, including cancer type (haematologic malignancy vs. non-haematologic malignancy) and time off cancer therapy (1–2 years, 2–5 years, 5–10 years and > 10 years). We also collected information related to the impact of COVID-19 on cancer survivors’ employment, substance use, physical activity and exercise, the impact of the COVID-19 pandemic on cancer care and finances (a full description of these variables is available in Supplemental Methods Sect. 2). We used self-report validated scales to assess psychological distress, loneliness and insomnia.

Psychological distress

Psychological distress was determined using the Kessler Psychological Distress Scale (K-10). The K-10 consists of ten questions about emotional states within the last one month. Possible responses consist of “none of the time”, “a little of the time”, “some of the time”, “most of the time”, and “all of the time” and are graded as 1–5, respectively. The total K-10 score was calculated by summing the scores from each of the ten questions. Individuals with a total score ≥ 25 were classified as having high (moderate to severe) psychological distress [22, 23].

Loneliness

The 3-item UCLA Loneliness Score was used to assess self-reported loneliness among survivors over the four weeks preceding the survey. This validated score consists of three questions that assess how often participants feel they lack companionship, feel left out and feel isolated from others. Participants can answer "hardly ever", "some of the time", or "often" for each of the three questions, and those answered are scored as 1, 2, or 3, respectively. A final score is derived from the sum of the three question scores. Individuals with a cumulative score ≤ 5 are considered not lonely, and individuals with a cumulative score ≥ 6 are considered lonely [24, 25].

Insomnia symptoms

We used the Insomnia Severity Index (ISI), a validated self-report scale to assess the nature and severity of insomnia symptoms; this consists of seven questions and has been validated to assess insomnia in individuals with cancer [26, 27]. Participants were asked to rate their difficulty falling asleep, difficulty staying asleep, and problems waking up too early within the last two weeks as “none”, "mild", "moderate", "severe" or "very severe," and the answers to these three questions were scored as 0–4, respectively. Survivors were then asked four questions related to satisfaction/dissatisfaction with sleep, noticeability of sleep problems, worry/distress about people’s problems and interference of sleep problems with daily life. These questions were also scored from 0 to 4. The scores of all seven questions were combined to yield a final ISI score. Participants with scores ≥ 15 were classified as having moderate-to-severe insomnia [26, 28].

Statistical analysis

Demographic and clinical variables related to the impact of COVID-19 pandemic were summarized using descriptive statistics. Factors associated with high psychological distress, loneliness and insomnia were investigated using logistic regression. Simple logistic regression with odds ratios and 95% confidence limits were used to estimate the independent association between high psychologic distress (yes vs. no), loneliness (yes vs. no) and moderate-to-severe insomnia (yes vs. no) and pre-determined variables such as age, sex, ethnicity, geographic location, employment status, personal income, cancer type, presence of self-reported pre-pandemic mental health condition, pre-existing chronic physical health condition, relationship status, the impact of the pandemic on employment, finances, substance use, cancer care and physical activity. Multivariable logistic regression was then performed with factors with a p-value < 0.1 on univariable analysis to determine association with psychologic distress, loneliness and insomnia while adjusting for the influence of other variables. Statistical significance was defined as p-value less than 0.05, and two-sided tests were used. SPSS version 28.0 was used to perform the analysis [29].

Results

Demographic data

Of the 1063 individuals who completed the initial survey, 384 were at least one year off cancer treatment and were eligible for this analysis. The reasons for exclusion were: on cancer treatment or within one year of finishing treatment (n = 656), did not specify the stage of treatment (n = 15), age < 18 (n = 2), and age > 50 years (n = 6). The demographic and clinical data for the cohort are displayed in Table 1. The median age of participants was 30 years. Most patients had recently completed therapy, with 262 (68.2%) having completed therapy within the past 2 years, 110 (28.6%) having completed therapy within the past 2–5 years and only 12 (3.1%) having completed therapy within the past 5–10 years. Men (N = 218) constituted 57.2% of the study population. Most participants were white (N = 357, 93.0%), and two-thirds of the participants lived in an urban location (N = 256, 67.0%). The number of survivors engaged in physical activity of 30 min/day for 0 days, 1–2 days, 2–4 days and 5–7 days per week was 9 (2.4%), 81 (21.3%), 190 (49.9%) and 101 (26.5%), respectively. Seventy-seven (20.4%) participants reported a pre-pandemic mental health condition, and 165 (43.0%) of participants reported a pre-existing chronic physical health condition. The majority of participants had non-haematologic malignancies (N = 301, 78.4%).
Table 1

Demographics of the study population (n = 384)

Study variablen%
Age (years)
  18–257820.3%
  26–3928173.2%
  40–50256.5%
Gender*
  Man21857.2%
  Woman16342.8%
Ethnicity
  White35793.0%
  Non-white277.0%
Province or Territory
  Central Canadaa7820.3%
  Prairiesb12432.3%
  British Columbia4311.2%
  Atlantic Canadac9925.8%
  Canadian Territoriesd4010.4%
Living Environment**
  Urban25667.0%
  Rural or Remote12633.0%
Relationship Status**
  Single15239.8%
  In a relationship23060.2%
Employment Status†e
  Employed (part or full time)24965.5%
  Student4712.4%
  Unemployed5915.5%
  Caregiver/homemaker133.4%
  Disability or unemployment benefits92.4%
  Other (Eg.Leave of absence)30.8%
Personal income in 2020 (CAD$)
  < $40,0009024.4%
  $40,000—< $60,00014439.0%
  ≥ $60,00013536.6%
Cancer type
  Haematologic malignancy8321.6%
  Non-haematologic malignancy30178.4%
Time off of cancer therapy
  1–2 years26268.2%
  2–5 years11028.6%
  5–10 years123.1%
  > 10 years00.0%
Pre-pandemic mental health condition
  Yes7720.4%
  No30079.6%
Pre-existing chronic physical health illnessg
  Yes16543.0%
  No21957.0%
Number of days/week of physical activity or exercise*
  0 days92.4%
  1–2 days8121.3%
  2–4 days19049.9%
  5–7 days10126.5%

a Ontario, Quebec; b Alberta, Saskatchewan, Manitoba; c Newfoundland and Labrador, Nova Scotia, New Brunswick, Prince Edward Island; dYukon, Northwest Territories, Nunavut; eMultiple option choices could be selected; fEg. Personality disorder, ADHD; g Eg. Autoimmune diseases, seizure disorder

*N = 381, ** = N = 382, †N = 380, ‡N = 369, §N = 377, ††N = 378, ‡‡N = 373, §§N = 379, *†N = 368, *§N = 372, †§N = 354

Demographics of the study population (n = 384) a Ontario, Quebec; b Alberta, Saskatchewan, Manitoba; c Newfoundland and Labrador, Nova Scotia, New Brunswick, Prince Edward Island; dYukon, Northwest Territories, Nunavut; eMultiple option choices could be selected; fEg. Personality disorder, ADHD; g Eg. Autoimmune diseases, seizure disorder *N = 381, ** = N = 382, †N = 380, ‡N = 369, §N = 377, ††N = 378, ‡‡N = 373, §§N = 379, *†N = 368, *§N = 372, †§N = 354

Impact of COVID-19 pandemic on employment, finances, cancer care, physical activity, substance use, and COVID-19 pandemic-related worries

Figure 1 shows the impact of COVID-19 pandemic on employment, finances, cancer care, physical activity and substance use. The number of AYA cancer survivors who reported that pandemic affected their employment was 284 (73.9%): 85 (22.1%) quit, 105 (27.3%) were laid off and 94 (24.5%) were laid off but were working again at the time of the survey. Nearly two-thirds (66.5%) of survivors conveyed that their finances got worse during the pandemic. A negative impact of the pandemic on cancer care was reported by 83 (21.8%) of survivors. More physical activity, the same level of physical activity and less physical activity compared to pre-pandemic were reported by 47 (12.3%), 203 (53.1%) and 124 (32.5%) of survivors, respectively, while 8 (2.1%) indicated that they do not exercise. Increased substance use during pandemic was reported by 73 (19.2%) of survivors, while 103 (27.0%) reported a reduction in substance intake when compared to pre-pandemic years. Supplemental Fig. 1 shows the worries of the survivors related to the COVID-19 pandemic. Worries about contracting COVID-19 infection, cancer treatment increasing the risk of acquiring COVID-19 infection, having poor health outcomes from contracting COVID-19 infection, and finances were reported by 45.6%, 55.0%, 47.3% and 46.0% of survivors, respectively.
Fig. 1

Self-reported impact of COVID-19 pandemic on employment, finances, cancer care, substance use, and physical activity 

Self-reported impact of COVID-19 pandemic on employment, finances, cancer care, substance use, and physical activity

Psychological distress

High psychological distress was reported by 68.9% (N = 257) of survivors. On univariable analysis, increasing age, male gender, rural living environment, higher income and presence of a pre-existing chronic physical health condition were associated with a greater odds of experiencing high psychological distress (p < 0.05). On multivariable analysis, the factors independently associated with high psychological distress were an income greater than or equal to $60,000 in the year 2020 (adjusted odds ratio [AOR] 2.15, 95% CI 1.11–4.17, p = 0.02) and the presence of a chronic physical health condition (AOR 2.05, 95%CI 1.18–3.56, p = 0.01) (Table 2).
Table 2

Psychological distress among survivors of AYA cancers during the COVID-19 pandemic

Univariable analysisMultivariable analysis (n = 359)
VariableOdds Ratio95% CIP-ValueAdjusted Odds Ratio95% CIP-Value
Age (continuous)0.950.92–0.990.0150.960.92–1.0040.078
Gender
  - Female0.620.40–0.970.0340.820.50–1.350.43
  - Male (ref)
Ethnicity
  - Not white2.700.91–7.980.0730.540.17–1.740.30
  - White (ref)
Living environment
  - Rural/remote2.731.61–4.62 < 0.0011.530.85–2.790.16
  - Urban (ref)
Employment status
  - Unemployed2.300.96–5.510.14
  - Student1.600.88–2.90
  - Employed (ref)
Impact of COVID-19 pandemic on employment1.250.71–2.200.44
  - Impacted
  - No impact (ref)
Personal income in the year 2020
  - $60,000 or more1.470.85–2.550.0012.151.11–4.170.024
  - $40,000 to less than $60,0003.041.66–5.701.010.55–1.860.97
  - Less than $40,000 (ref)
Effect of COVID-19 pandemic on finances
  - Worse0.750.44–1.260.39
  - Better1.120.43–2.95
  - Same (ref)
Cancer type
  - Haematologic1.180.68–2.020.56
  - Non-haematologic (ref)
Time off cancer treatment
  - 5–10 years0.520.15–1.770.57
  - 2–5 years0.990.61–1.64
  - 1–2 years (ref)
Pre-pandemic mental health condition
  - Yes1.360.76–2.410.29
  - No (ref)
Pre-existing chronic physical health condition
  - Yes3.091.90–5.02 < 0.0012.051.18–3.560.011
  - No (ref)
Relationships status
  - Single1.020.65–1.600.92
  - In relationship (ref)
Substance use during the pandemic
  - Better0.630.35–1.120.151
  - Worse1.180.58–2.40
  - Same (ref)
Negative impact of pandemic on cancer care
  - Yes0.880.52–1.480.62
  - No (ref)
Impact of COVID-19 pandemic on physical activity/exercise
  - More active0.690.44–1.730.70
  - Less active0.410.50–1.33
  - Same level of activity (ref)
Psychological distress among survivors of AYA cancers during the COVID-19 pandemic

Loneliness

Loneliness was reported by 204 (54.0%) of survivors. On univariable analysis, unemployment, COVID-19 pandemic negatively affecting finances and presence of a pre-pandemic mental health condition were associated with a greater odds of experiencing loneliness (p < 0.0.05). On multivariable analysis, the factors independently associated with loneliness were an employment status of unemployed (AOR 2.26 95% CI 1.18–4.31, p = 0.013), pandemic causing finances to be worse (AOR 1.82, 95% CI 1.08–3.06, p = 0.024) and the presence of a pre-pandemic mental health condition (AOR 1.88, 95% CI 1.03–3.42, p = 0.038) (Table 3).
Table 3

Loneliness among survivors of AYA cancers during the COVID-19 pandemic

Univariable analysisMultivariable analysis (n = 332)
Odds ratio95% CIP-ValueAdjusted odds ratio95% CIP-Value
Age (continuous)1.020.98–1.050.36
Gender
  - Female1.150.76–1.740.50
  - Male (ref)
Ethnicity
  - Not white1.260.57–2.800.57
  - White (ref)
Living environment
  - Rural/remote0.800.52–1.230.31
  - Urban (ref)
Employment status
  - Unemployed2.261.23–4.160.0272.261.18–4.310.013
  - Student0.950.51–1.780.920.48–1.770.81
  - Employed (ref)
Impact of COVID-19 pandemic on employment0.880.52–1.490.63
  - Impacted
  - No impact (ref)
Personal income in the year 2020
  - $60,000 or more0.720.42–1.240.49
  - $40,000 to less than $60,0000.840.49–1.46
  - Less than $40,000 (ref)
Effect of COVID-19 pandemic on finances
  - Worse1.821.13–2.930.0471.821.08–3.060.024
  - Better1.460.65–3.361.330.54–3.260.54
  - Same (ref)
Cancer type
  - Haematologic0.820.50–1.330.42
  - Non-haematologic (ref)
Time off cancer treatment
  - 5–10 years1.090.33–2.680.62
  - 2–5 years1.260.80–1.98
  - 1–2 years (ref)
Pre-pandemic mental health condition
  - Yes2.301.34–3.950.021.881.03–3.420.038
  - No (ref)
Pre-existing chronic physical health condition
  - Yes1.330.88–2.000.17
  - No (ref)
Relationships status
  - Single0.900.59–1.360.61
  - In relationship (ref)
Substance use during the pandemic
  - Better1.470.88–2.460.33
  - Worse1.260.71–2.23
  - Same (ref)
Negative impact of pandemic on cancer care
  - Yes0.830.56–1.510.75
  - No (ref)
Impact of COVID-19 pandemic on physical activity/exercise
  - More active0.870.46–1.640.36
  - Less active1.330.84–2.10
  - Same level of activity (ref)
Loneliness among survivors of AYA cancers during the COVID-19 pandemic

Insomnia Symptoms

Moderate-to-severe insomnia symptoms were reported by 74 (19.5%) survivors. On univariable analysis, employment status of unemployed or student, having a diagnosis of a haematologic malignancy, longer time off cancer therapy, having a pre-pandemic mental health condition, being single, COVID-19 pandemic having a negative impact on cancer care and having increased substance use during pandemic were associated with increased odds of experiencing moderate-to-severe insomnia, while reduced substance use was associated with decreased odds of experiencing moderate-to-severe insomnia among AYA cancer survivors (p < 0.05). On multivariable analysis, the factors independently associated with moderate-to-severe insomnia symptoms were having an employment status as a student (AOR 3.00, 95% CI 1.08–8.29, p = 0.035) or unemployed (AOR 3.97, 95% CI 1.46–10.83, p = 0.007), earning $60,000 or more in the year 2020 (AOR 4.36, 95% CI 1.43–13.32, p = 0.010), having haematologic cancer (AOR 2.21, 95% CI 1.05–4.70, p = 0.039), and being single (AOR 2.52, 95% CI 1.08–5.91, p = 0.033) (Table 4).
Table 4

Insomnia among survivors of AYA cancers during the COVID-19 pandemic

Univariable analysisMultivariable analysis (n = 279)
VariableOdds Ratio95% CIP-ValueAdjusted Odds Ratio95% CIP-Value
Age (continuous)1.010.97–1.050.700.630.30–1.330.23
Gender
  - Female0.620.40–0.970.034
  - Male (ref)
Ethnicity
  - Not white2.020.59–6.900.26
  - White (ref)
Living environment
  - Rural/remote1.150.67–1.950.62
  - Urban (ref)
Employment status
  - Unemployed2.791.45–5.380.0093.971.46–10.830.007
  - Student1.510.69–3.303.001.08–8.290.035
  - Employed (ref)
Impact of COVID-19 pandemic on employment1.140.56–2.330.71
  - Impacted
  - No impact (ref)
Personal income in the year 2020
  - $60,000 or more1.270.68–2.430.0604.361.43–13.320.010
  - $40,000 to less than $60,0000.610.31–1.230.950.32–2.820.93
  - Less than $40,000 (ref)
Effect of COVID-19 pandemic on finances
  - Worse0.650.37–1.140.30
  - Better0.590.20–1.72
  - Same (ref)
Cancer type
  - Haematologic2.701.53–4.66 < 0.001 2.21 1.05-4.700.039
  - Non-haematologic (ref)
Time off cancer treatment
  - 5–10 years3.221.31–3.840.0060.440.026–7.400.57
  - 2–5 years2.240.90–11.52.010.94–4.310.072
  - 1–2 years (ref)
Pre-pandemic mental health condition
  - Yes2.101.18–3.740.0112.190.85–5.620.10
  - No (ref)
Pre-existing chronic physical health condition
  - Yes1.460.88–2.430.15
  - No (ref)
Relationships status
  - Single1.901.09–3.300.0252.521.08–5.910.033
  - In relationship (ref)
Substance use during the pandemic
  - Better0.720.35–1.500.0091.030.44–2.420.94
  - Worse2.231.14-.4.342.210.96–5.070.061
  - Same (ref)
Negative impact of COVID-19 pandemic on cancer care2.731.57–4.75 < 0.0012.050.87–4.840.10
  - Yes
  - No (ref)
Impact of COVID-19 pandemic on physical activity/ exercise
  - More active0.940.40–2.180.41
  - Less active1.410.82–2.45
  - Same level of activity (ref)
Insomnia among survivors of AYA cancers during the COVID-19 pandemic

Discussion

This study is the first to explore the experiences of the AYA cancer survivors during the COVID-19 pandemic in Canada. In this sample of 384 AYA survivors who were at least one-year post-completion of cancer therapy, we found that COVID-19 has impacted AYA cancer survivors in various ways. Specifically, we identified high levels of psychological distress (68.9%), insomnia (19.5%) and loneliness (54.0%). Given that cancer survivors are at an increased risk of many physical and mental health conditions, it is crucial to address modifiable risk factors for these conditions [28]. Substance use has been identified as one of the ways some individuals have attempted to cope with stress and emotions related to the loss of social connection and employment during the pandemic [30]. Prior studies have identified that childhood and AYA cancer survivors engage in risk-taking behaviours comparable to or higher than their peers [31, 32]. In our study, although 27.0% reported improvement in substance use during the pandemic, 19.2% conveyed that their substance use worsened. A similar pattern in substance use has been observed in the general Canadian population [33]. As substance use can further increase the risk of physical and psychological morbidities among AYA cancer survivors, efforts for screening and reducing substance use are crucial for this population, especially during a pandemic. At the same time, recognizing the factors that lead to a reduction in substance use during the pandemic might assist in shaping future strategies for preventing substance misuse. The decline in the physical activity reported by more than half of the participants is concerning, given the growing body of literature on the vital role of exercise in mitigating the long-term physical, psychological and cognitive sequelae of cancer and its treatment [34]. To prevent the long-term consequences of a sedentary lifestyle, developing novel and creative ways or programs to engage survivors in various physical activities and prevent the persistence of sedentary behaviours acquired during the pandemic is paramount. During the pandemic, AYA cancer survivors had a significant decline in their finances and employment. Prior to the COVID-19 pandemic, adult and childhood cancer survivors were at an elevated risk for financial hardships and were less likely to be employed [35-37]. Half (49.4%) of AYA cancer survivors in our survey reported quitting their job or being laid off, and 66.5% reported that the pandemic negatively affected their finances [38]. The finances of youth have been disproportionately affected during the pandemic, and their re-employment rates have been lower than their older counterparts; this gap may be further exaggerated for AYA cancer survivors, who already face challenges and stigma when seeking employment [39]. Programs specifically designed and targeted to cancer survivors must be created through the joint efforts of cancer organizations, non-profits and local governments to support survivors overcome their unique barriers to workforce re-entry such as restricted mobility, cognitive impairment, chronic pain, fatigue, need for reduced work hours or special accommodations. Programs targeted to the general population should also be promoted to cancer survivors to support these individuals' financial health and equal employment opportunities as we continue to navigate this pandemic. The changes in the social fabric of Canadian society as a consequence of COVID-19 precautionary measures have had a significant impact on the mental health of Canadians, and the same holds for cancer survivors. In our study, 68.9% of survivors reported high psychological distress, which is considerably greater than pre-pandemic reports of psychological distress among AYA cancer survivors (21–29.5%) [10, 40]. Pre-pandemic studies also suggest that AYA cancer survivors report significantly higher psychological distress than cancer-free peers [41]. This association holds during the pandemic, with only 17–24% of Canadian teenagers without a history of cancer reporting symptoms of psychological distress [42]. In our analysis, AYA survivors with a pre-existing physical health issue reported higher levels of psychological distress. This is potentially because a pre-existing physical health issue, and being a cancer survivor are independent contributors to psychological distress [43, 44]. This finding also aligns with a recently conducted systematic review reporting higher levels of psychological distress among people with pre-existing chronic health conditions in the general population during this pandemic [45]. We also identified a personal income of $60,000 or more in the year 2020 as a risk factor for psychological distress. This finding needs further exploration since it can be confounded by other elements not accounted for in this analysis, such as the Canada Emergency Response Benefit provided by the Canadian government during the pandemic to some individuals, education status, child care responsibilities, homeschooling during the pandemic, work environment and the household income [46]. In addition, more than half (54%) of AYA cancer survivors met the criteria for loneliness. Compared to a cohort of young adults in Canada without a history of cancer surveyed in November 2020, the prevalence of loneliness in our study was considerably greater (54% vs. 29%) [47]. Compared to two other studies reporting the prevalence of loneliness during the pandemic to be 21–40% among patients with cancer of varying ages, AYAs with cancer were more likely to report loneliness [17, 48]. A pre-pandemic study of AYAs with cancer identified these individuals to be more lonely than peers without a history of cancer [49]. AYA cancer survivors with a pre-existing mental health condition were more likely to identify as lonely in our study, which may result from poor coping skills, their pre-existing diagnosis increasing their vulnerability to social isolation and the financial consequences of the pandemic. In addition, unemployed individuals were also more likely to report being lonely, a finding comparable to studies of individuals without a cancer diagnosis [50]. Participants whose finances became worse during the pandemic were also more likely to report loneliness. Individuals whose finances have deteriorated may not engage in standard coping mechanisms, have food and shelter insecurity, and increased interpersonal conflict at home regarding finances due to their declining income, causing a survivor to feel lonelier [51, 52]. As loneliness has been shown to predict suicidal ideation and can have a negative impact on long-term physical and mental health, the high prevalence of loneliness among AYA cancer survivors is of significant concern and needs attention during this pandemic [53, 54]. Nearly 20% of AYA cancer survivors reported moderate-to-severe insomnia symptoms. A pre-pandemic report found that insomnia occurred in 30% of cancer survivors; however, that study used a different insomnia questionnaire and was not restricted to only AYAs, making it difficult to compare our results [28]. Another study of sleep in young adult cancer survivors during the COVID-19 pandemic using the ISI found a reduction in insomnia during the pandemic (50.3% pre-pandemic vs. 34.3% during the pandemic). However, this study used an ISI cut-off of 8 (mild insomnia), where we used a cut-off of 15 (moderate/severe insomnia) [55]. A significant increase in insomnia and disordered sleep has been reported in numerous populations during the COVID-19 pandemic [56-58]. However, the rate of insomnia in our sample is comparable to the studies using ISI to measure insomnia among the general population during pandemic (20% vs. 18.6% and 19.1%) [59, 60]. We demonstrated that survivors who were students, had a haematologic malignancy or were single were more likely to report insomnia. These variables may be a source of increased stress and uncertainty, contributing to insomnia [61]. Students are at high risk of insomnia due to varying routines and periods of intense stress, leading to nearly 60% of university students reporting poor sleep [45]. Being a student with a previous history of cancer during the COVID-19 pandemic comes with additional stressors such as impacts of the pandemic on cancer care and the inability to meet in person with their support networks [62]. We also demonstrated that survivors with an income of ≥ $60,000 were at an increased risk of experiencing insomnia. A similar association of higher incomes with high psychological distress was identified in our study. The association of income with insomnia may be confounded by similar factors confounding the impact of income on psychological distress that were not accounted for in this analysis. Insomnia has a bidirectional relationship with depression and can profoundly impact the quality of life, making it a crucial issue to address [63]. Effective insomnia interventions such as cognitive behavioural therapy delivered via in-person or digital format should be available to the survivors with sleep issues [64, 65]. Our study has some important limitations to address. First, our cohort of AYA cancer survivors may not represent all AYA cancer survivors. For instance, most of our cohort was white (93.0% vs. 72.6% of Canadians), and no survivors identified themselves as being from a gender minority group (vs. 0.24% of Canadians) [66]. Individuals from these minoritized groups have been disproportionately affected by the pandemic; thus, the experiences of AYAs belonging to these groups may differ from those in our cohort [67, 68]. Individuals with limited access to technology may not have been able to access our survey, and these individuals may have had distinct challenges during the pandemic. Interestingly, a systematic review assessing the sample metrics of virtual versus traditional recruitment methods found virtually recruited samples to be more geographically diverse [69]. Comparison of the demographics of our cohort to a pre-pandemic Canadian survey of AYAs with cancer using both online and paper methods for recruitment revealed that our sample had a greater proportion of rural participants (33% vs. 21%), suggesting that our online recruitment strategy did not compromise geographic diversity [70]. Our cohort also has very few survivors who completed therapy five or more years ago (3.1%). Cancer survivors who are further out from therapy are less likely to seek care in a cancer centre and be involved with support groups and therefore might have been unaware of our study. It is necessary to further study the impact of the COVID-19 pandemic on individuals who are more than five years out from cancer therapy. Our study was done at a single time point during the pandemic when most Canadian provinces were under lockdowns during the second wave of the pandemic. These results may vary as the pandemic goes on for a longer time. The absence of a control group limited our ability to estimate the impact of the pandemic on AYA cancer survivors compared to AYAs without cancer. To combat this limitation, we compared our data to the surveys done in the general population during the pandemic, which, although not ideal, provided more insights into the results. Finally, the presence of distress, loneliness and insomnia might have been overestimated in this cohort of survivors as they were recruited from national AYA support groups. In summary, we demonstrated that the COVID-19 pandemic had significantly impacted the finances, employment, physical activity, substance use behaviours and cancer care of AYA cancer survivors. Furthermore, we identified that these cancer survivors report higher rates of psychological distress, insomnia and loneliness that require urgent attention. Cancer organizations, non-profit cancer support organizations, primary care providers and the government should focus on developing new programs and promoting existing programs to help mitigate the adverse effects of the COVID-19 pandemic on cancer survivors. This is particularly important as the pandemic continues into subsequent waves as the prolonged nature of lockdowns and restrictions may further worsen these challenges. Below is the link to the electronic supplementary material. Supplementary file1 (DOCX 35 KB)
  60 in total

1.  Validation of the Insomnia Severity Index as an outcome measure for insomnia research.

Authors:  C H. Bastien; A Vallières; C M. Morin
Journal:  Sleep Med       Date:  2001-07       Impact factor: 3.492

2.  Health-related quality of life of adolescent and young adult patients with cancer in the United States: the Adolescent and Young Adult Health Outcomes and Patient Experience study.

Authors:  Ashley Wilder Smith; Keith M Bellizzi; Theresa H M Keegan; Brad Zebrack; Vivien W Chen; Anne Victoria Neale; Ann S Hamilton; Margarett Shnorhavorian; Charles F Lynch
Journal:  J Clin Oncol       Date:  2013-05-06       Impact factor: 44.544

3.  Patterns of unmet needs in adolescent and young adult (AYA) cancer survivors: in their own words.

Authors:  Alex W K Wong; Ting-Ting Chang; Katrina Christopher; Stephen C L Lau; Lynda K Beaupin; Brad Love; Kim L Lipsey; Michael Feuerstein
Journal:  J Cancer Surviv       Date:  2017-03-29       Impact factor: 4.442

Review 4.  Insomnia in the context of cancer: a review of a neglected problem.

Authors:  J Savard; C M Morin
Journal:  J Clin Oncol       Date:  2001-02-01       Impact factor: 44.544

Review 5.  A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for insomnia (CBT-I) in cancer survivors.

Authors:  Jillian A Johnson; Joshua A Rash; Tavis S Campbell; Josée Savard; Philip R Gehrman; Michael Perlis; Linda E Carlson; Sheila N Garland
Journal:  Sleep Med Rev       Date:  2015-08-01       Impact factor: 11.609

6.  Short screening scales to monitor population prevalences and trends in non-specific psychological distress.

Authors:  R C Kessler; G Andrews; L J Colpe; E Hiripi; D K Mroczek; S L T Normand; E E Walters; A M Zaslavsky
Journal:  Psychol Med       Date:  2002-08       Impact factor: 7.723

7.  Does age matter? Comparing post-treatment psychosocial outcomes in young adult and older adult cancer survivors with their cancer-free peers.

Authors:  Michael J Lang; Janine Giese-Davis; Scott B Patton; David J T Campbell
Journal:  Psychooncology       Date:  2017-08-04       Impact factor: 3.894

8.  Cancer survivorship care during COVID-19-perspectives and recommendations from the MASCC survivorship study group.

Authors:  Alexandre Chan; Fred Ashbury; Margaret I Fitch; Bogda Koczwara; Raymond Javan Chan
Journal:  Support Care Cancer       Date:  2020-08       Impact factor: 3.603

9.  Sleep quality and insomnia during the COVID-19 lockdown among the Saudi public: A cross-sectional study.

Authors:  Adel S Alharbi; Sultan M Alshahrani; Muslim M Alsaadi; Hamdan H Al-Jahdali; Siraj O Wali; Ahmed S BaHammam
Journal:  Saudi Med J       Date:  2021-04       Impact factor: 1.422

10.  Material, behavioral, and psychological financial hardship among survivors of childhood cancer in the Childhood Cancer Survivor Study.

Authors:  Douglas Fair; Elyse R Park; Ryan D Nipp; Julia Rabin; Kelly Hyland; Karen Kuhlthau; Giselle K Perez; Paul C Nathan; Gregory T Armstrong; Kevin C Oeffinger; Leslie L Robison; Wendy Leisenring; Anne C Kirchhoff
Journal:  Cancer       Date:  2021-06-01       Impact factor: 6.921

View more
  1 in total

1.  The Transformation of Adolescent and Young Adult Oncological and Supportive Care in Canada: A Mixed Methods Study.

Authors:  Jonathan Avery; Emily Wong; Christine Harris; Stacy Chapman; Serena Uppal; Shaayini Shanawaz; Annemarie Edwards; Laura Burnett; Tushar Vora; Abha A Gupta
Journal:  Curr Oncol       Date:  2022-07-20       Impact factor: 3.109

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.